Concepedia

Author

Andre Fouquet

Merck (United Kingdom)

Also Known As

A Fouquet, A. FOUQUET, Andre Fouquet

8

Publications

213

Citations

6

H-Index

13

Concepts

All Affiliations

Merck (United Kingdom)NHS LanarkshireMerck & Co., Inc., Rahway, NJ, USA (United States)
AF

About

Andre Fouquet is an author at Merck (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

150

2

Pharmacology

4

4

150

3

Natural Sciences

2

2

36

4

Biochemistry

2

2

36

5

Chemical Biology

1

1

11

Andre Fouquet

×

5

Publications

201

Citations

5

H-Index

YearCitations

Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazoles

Andre Fouquet, Daniel Provost, M. de Cazes,

Journal of Medicinal Chemistry

1992

102

Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1

Dominique Potin, Michèle Launay, Francoise Monatlik,

Journal of Medicinal Chemistry

2006

51

Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr,

Bioorganic & Medicinal Chemistry Letters

2010

25

2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors

Jiaqiang Cai, David Jonathan Bennett, Zoran Ranković,

Bioorganic & Medicinal Chemistry Letters

2010

12

Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: Improving selectivity over hERG

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr,

Bioorganic & Medicinal Chemistry Letters

2010

11

Page 1